Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration (FDA) has approved Watson Laboratories' Nabumetone Tablets USP, 500mg and 750mg.
Subscribe to our email newsletter
Nabumetone Tablets are indicated for the relief of signs and symptoms of osteoarthritis and rheumatoid arthritis.
Watson‘s Nabumetone is a nonsteroidal anti-inflammatory drug (NSAID) that shows anti-inflammatory, analgesic and antipyretic properties in pharmacologic studies.
The drug contains colloidal silicon dioxide, D&C yellow #10 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium lauryl sulfate, sodium starch glycolate and titanium dioxide.
The company expects to make the product available in the market soon.